BACKGROUND
Bone marrow-derived cell therapy has been investigated in patients with severe liver disease.
OBJECTIVE
To assess the feasibility, safety and cell kinetics of autologous bone marrow-derived mononuclear cells (BMMCs) infusion in cirrhotic patients.
METHODS
BMMCs were isolated from